Hypothesis is first-of-its-kind eczema skincare powered by TPZ-01™, a patented enzyme that specifically targets Staphylococcus aureus, the bacteria behind flare-ups, while preserving the skin's beneficial microbiome. Founded by four scientists who have spent decades researching the microbiome, our mission is deeply personal: to radically change how eczema is treated.
| Website | https://www.hypothesis.bio |
| Employees | 6 (3 on RocketReach) |
| Founded | 2025 |
| Industry | Retail Health and Personal Care Products |
Looking for a particular hypothesis.bio employee's phone or email?
Oliver Liu is the Co-Founder of hypothesis.bio.
3 people are employed at hypothesis.bio.